Integration of Medicine and Industry | Party Secretary Guo Changchun of Pingshan Central Hospital Visits Shenzhen Cell Valley for Exchange

On July 25, Guo Changchun, Party Secretary of Pingshan Central Hospital; Yan Shi, Director of the Traditional Chinese Medicine Department and Head of the Science and Education Division; Zhu Lepan, Director of the Laboratory Department; Wang Wei, Director of the Pathology Department; and young physician Liu Yan visited Shenzhen Cell Valley for exchange and discussion. Our Chairman, Shi Yuanyuan; Assistant to the Chairman, Wei Zheng; Head of Marketing, Sun Rui; and Head of Precision Medicine, Fu Yuchen, extended a warm welcome and engaged in discussions on future directions for cooperation.

Chairman Shi Yuanyuan extended a warm welcome to Secretary Guo Changchun and his delegation. During the tour of the smart exhibition hall, he elaborated on Shenzhen Cell Valley's strategic positioning, technological uniqueness, and future development directions, and introduced the founding team with their professional backgrounds and shared vision. Chairman Shi also reviewed the company's development journey, emphasizing the critical role of public service platform construction as a bridge in the cell therapy industry chain. Building on continuous exploration in platform development, the company has now successfully established substantive research and clinical collaborations with multiple well-known domestic hospitals.

During the symposium, Chairman Shi provided a detailed introduction to the current state of cell therapy both domestically and internationally, the company's core technologies, and its R&D team. Chairman Shi noted that cell therapy is gradually establishing itself as a new direction for the development of the healthcare industry, suggesting that future clinical cell therapy models may comprehensively cover the entire treatment cycle, achieving full-spectrum precision medical services. Recently, Shenzhen Cell Valley has successfully provided patients with high-quality CAR cell preparations targeting different targets, using self-produced industrial-grade retroviral vectors, with notable therapeutic efficacy.

Secretary Guo Changchun highly praised the positive clinical outcomes achieved by Cell Valley and introduced the hospital's development progress. Secretary Guo stated that Pingshan Central Hospital actively responds to the district committee and district government's higher development and construction requirements, adhering to a new integrated development path combining medical care, industry, research, and education. The Central Hospital encourages deep collaboration with biopharmaceutical-related industries within the district to jointly promote innovative development in the Pingshan biopharmaceutical industry. The hospital has shown great interest and anticipation for the major breakthroughs made by Shenzhen Cell Valley's core technologies and R&D team in the biopharmaceutical field. Secretary Guo expressed that the Central Hospital will engage in closer cooperation with Shenzhen Cell Valley, fully leveraging Cell Valley's research achievements and technological advantages to jointly promote the clinical application of cutting-edge technologies such as cell and gene therapy.

Both parties expressed that cell therapy will become a key pillar of the healthcare industry in the future. Through in-depth future cooperation, they will jointly drive innovation and breakthroughs in the cell therapy field, contributing more to the advancement of human health.